In Vivo is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Angiotech nets $17mm in an IPO of 2.4mm common shares
05 Aug 1999
Angiotech Pharmaceuticals, a company with a focus on treatments for inflammatory and angiogenesis-dependent diseases, has netted $17.1mm (Cdn$23.7mm) (including greenshoe) in an IPO of 2.4mm common shares at $7 (Cdn$10) each.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?